Transpact Enterprises Ltd Intrinsic Value
TRANSPACTENTERPRISESLTD · Healthcare · Current price ₹190.35
Is Transpact Enterprises Ltd undervalued?
DocStoX estimates the fair value of Transpact Enterprises Ltd at ₹12 per share, versus the current market price of ₹190. That puts the stock about -93.7% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 1 independent method: Residual income (₹12). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹10 (bear) to ₹12 (base) to ₹14 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
Margin of safety
Value investors demand a margin of safety — a discount to intrinsic value that protects against being wrong. At ₹190 versus an intrinsic value of ₹12, Transpact Enterprises Ltd currently offers -93.7% of negative margin (i.e. a premium).
More on Transpact Enterprises Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.